RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
RedHill Biopharma將於明天獲得美國專利,編號爲11,918,560,標題爲 “用於治療冠狀病毒感染的絲氨酸蛋白酶抑制劑”
RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
RedHill Biopharma將於明天獲得美國專利,編號爲11,918,560,標題爲 “用於治療冠狀病毒感染的絲氨酸蛋白酶抑制劑”
使用瀏覽器的分享功能,分享給你的好友吧